tradingkey.logo
tradingkey.logo
Search

Transmedics Group Inc

TMDX
Add to Watchlist
72.260USD
+1.130+1.59%
Close 07-24 16:00ETQuotes delayed by 15 min
2.50BMarket Cap
14.31P/E TTM

Transmedics Group Inc

72.260
+1.130+1.59%
View Detailed Chart
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

+1.59%

5 Days

-2.32%

1 Month

+5.58%

6 Months

-48.14%

Year to Date

-40.60%

1 Year

-33.17%

Key Figures
72.380Open
73.860High
1.14MVolume
14.31P/E TTM
22.61P/E Dynamic
--Dividend TTM
3.30%Turnover Ratio
71.130Prev. Close
68.800Low
63.88MTurnover
70.39P/E Static
5.05P/B
0.00%Div Yield TTM
15.13%ROA
156.00052wk High
1.27Volume Ratio
35.46MNet Profit
34.55MShares
5.0490EPS TTM
1.94Beta
45.22%ROE
60.10552wk Low
7.11%Amplitude
58.16%Gross Margin
2.50BMarket Cap
1.26Reward/Risk
3.12%Risk Rate

Key Insights

Transmedics Group Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 15 out of 200 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 119.56.In the medium term, the stock price is expected to trend down.Despite a good stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Transmedics Group Inc's Score

Industry at a Glance

Industry Ranking
15 / 200
Overall Ranking
59 / 4279
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Positive

Transmedics Group Inc Highlights

StrengthsRisks
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 150.59% year-on-year.
Fairly Valued
The company’s latest PE is 14.31, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 42.29M shares, decreasing 3.95% quarter-over-quarter.
Held by John Hussman
Star Investor John Hussman holds 44.62K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.18.

Analyst Rating

Based on 12 analysts
Buy
Current Rating
118.444
Target Price
+66.52%
Upside Space

Transmedics Group Inc News

More news coming soon, stay tuned...

Earnings Forecast

Analyst Rating

Based on 12 analysts
Buy
Current Rating
118.444
Target Price
+66.52%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

88
Total
4
Median
7
Average
Company name
Ratings
Analysts
Transmedics Group Inc
TMDX
12
Intuitive Surgical Inc
ISRG
35
Boston Scientific Corp
BSX
34
Edwards Lifesciences Corp
EW
33
Thermo Fisher Scientific Inc
TMO
30
Veeva Systems Inc
VEEV
30
1
2
3
...
18

Indicators

Indicators
Sell(2)
Neutral(4)
Buy(1)
Indicators
Value
Direction
MACD(12,26,9)
0.080
Neutral
RSI(14)
48.099
Neutral
STOCH(KDJ)(9,3,3)
30.471
Neutral
ATR(14)
3.298
Low Volatility
CCI(14)
-51.891
Neutral
Williams %R
62.038
Sell
TRIX(12,20)
0.065
Sell
StochRSI(14)
41.388
Buy
Moving Average
Sell(4)
Neutral(0)
Buy(2)
Indicators
Value
Direction
MA5
72.470
Sell
MA10
73.804
Sell
MA20
71.655
Buy
MA50
71.192
Buy
MA100
89.951
Sell
MA200
110.031
Sell

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Transmedics Group Inc Info

TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
Ticker SymbolTMDX
CompanyTransmedics Group Inc
CEOHassanein (Waleed H)
Websitehttps://www.transmedics.com/

Shareholders

Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.92%
Fidelity Management & Research Company LLC
12.93%
Vanguard Portfolio Management, LLC
5.55%
Vanguard Capital Management, LLC
4.28%
State Street Investment Management (US)
3.69%
Other
59.63%

FAQs

What is the current price of Transmedics Group Inc (TMDX)?

The current price of Transmedics Group Inc (TMDX) is 72.26.

What is the symbol of Transmedics Group Inc?

The ticker symbol of Transmedics Group Inc is TMDX.

What is the 52-week high of Transmedics Group Inc?

The 52-week high of Transmedics Group Inc is 156.00.

What is the 52-week low of Transmedics Group Inc?

The 52-week low of Transmedics Group Inc is 60.10.

What is the market capitalization of Transmedics Group Inc?

The market capitalization of Transmedics Group Inc is 2.50B.

Is Transmedics Group Inc (TMDX) currently rated as Buy, Hold, or Sell?

According to analysts, Transmedics Group Inc (TMDX) has an overall rating of Buy, with a price target of 118.44.

What is the Earnings Per Share (EPS TTM) of Transmedics Group Inc (TMDX)?

The Earnings Per Share (EPS TTM) of Transmedics Group Inc (TMDX) is 5.60.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.